2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Non–Small Cell Lung Cancer

Options for patients with non–small cell lung cancer have expanded following trials studying the safety and efficacy of checkpoint inhibitors and targeted therapies. Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center reviews the major abstracts from the 2019 ASCO Annual Meetin...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520733/
https://www.ncbi.nlm.nih.gov/pubmed/33364069
http://dx.doi.org/10.6004/jadpro.2019.10.6.7
Descripción
Sumario:Options for patients with non–small cell lung cancer have expanded following trials studying the safety and efficacy of checkpoint inhibitors and targeted therapies. Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center reviews the major abstracts from the 2019 ASCO Annual Meeting using coverage by The ASCO Post and offers considerations for advanced practitioners in this field.

Ejemplares similares